Usana Health Sciences Inc
USNANYSECIK 896264HealthcareFiscal year ends Jan 3
Reports and events: 249 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0520:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000896264-26-000060 |
| 2026-08-1318:37 ET | 10-Q | Quarterly reportPeriod 2026-07-04 | 0000896264-26-000056 |
| 2026-08-0420:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000050 |
| 2026-05-2020:24 ET | 8-K | 5.07 Shareholder vote results | 0000896264-26-000036 |
| 2026-05-1220:35 ET | 10-Q | Quarterly reportPeriod 2026-04-04 | 0000896264-26-000034 |
| 2026-05-0520:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000030 |
| 2026-04-0720:50 ET | DEF 14A | Proxy statementPeriod 2026-01-03 | 0000896264-26-000026 |
| 2026-03-3001:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-037181 |
| 2026-03-1618:57 ET | 10-K | Annual reportPeriod 2026-01-03 | 0000896264-26-000021 |
| 2026-02-1801:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000014 |
| 2026-02-1121:51 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000896264-26-000012 |
| 2026-01-1211:29 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000005 |
| 2026-01-0814:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000002 |
| 2025-11-0522:11 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0000896264-25-000224 |
| 2025-10-2220:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000213 |
| 2025-10-0920:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000210 |
| 2025-08-0520:50 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0000896264-25-000205 |
| 2025-07-2220:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000178 |
| 2025-07-0115:54 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000896264-25-000175 |
| 2025-05-2022:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events | 0000896264-25-000144 |
| 2025-05-0618:42 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0000896264-25-000126 |
| 2025-04-2220:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000119 |
| 2025-04-0421:11 ET | DEF 14A | Proxy statementPeriod 2024-12-28 | 0000896264-25-000105 |
| 2025-03-1219:36 ET | 10-K | Annual reportPeriod 2024-12-28 | 0000896264-25-000092 |
| 2025-03-0720:25 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000896264-25-000082 |
| 2025-02-2521:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000054 |
| 2024-12-2314:03 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-24-000235 |
| 2024-11-0517:56 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0000896264-24-000222 |
| 2024-10-2220:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-043281 |
| 2024-08-0616:42 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0000896264-24-000208 |
| 2024-07-2320:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-24-000180 |
| 2024-05-0720:01 ET | 8-K | 5.07 Shareholder vote results | 0000896264-24-000168 |
| 2024-05-0719:49 ET | 10-Q | Quarterly reportPeriod 2024-03-30 | 0000896264-24-000165 |
| 2024-04-3020:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-24-000138 |
| 2024-03-2217:24 ET | DEF 14A | Proxy statementPeriod 2023-12-30 | 0000896264-24-000119 |
| 2024-02-2721:26 ET | 10-K | Annual reportPeriod 2023-12-30 | 0000896264-24-000093 |
| 2024-02-0621:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-24-000176 |
| 2023-11-0719:09 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000896264-23-000030 |
| 2023-10-2420:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-001529 |
| 2023-08-0819:39 ET | 10-Q | Quarterly reportPeriod 2023-07-01 | 0000896264-23-000024 |
| 2023-07-2520:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-001145 |
| 2023-05-1220:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001157523-23-000832 |
| 2023-05-1120:15 ET | 8-K | 5.07 Shareholder vote results | 0001157523-23-000825 |
| 2023-05-0917:37 ET | 10-Q | Quarterly reportPeriod 2023-04-01 | 0000896264-23-000010 |
| 2023-05-0412:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-23-000729 |
| 2023-04-2520:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-000608 |
| 2023-03-3120:23 ET | DEF 14A | Proxy statement | 0001140361-23-015363 |
| 2023-02-2819:34 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000896264-23-000004 |
| 2023-02-1321:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-000267 |
| 2023-02-0721:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-000197 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.